Hideaki Miyake
Division of Urology
Kobe University Graduate School of Medicine
7-5-1 Kusunoki-cho
Chuo-ku
Japan
Name/email consistency: high
- Significance of docetaxel-based chemotherapy as treatment for metastatic castration-resistant prostate cancer in Japanese men over 75 years old. Miyake, H., Sakai, I., Harada, K., Muramaki, M., Fujisawa, M. Int. Urol. Nephrol (2012)
- Third-line sunitinib following sequential use of cytokine therapy and sorafenib in Japanese patients with metastatic renal cell carcinoma. Miyake, H., Kusuda, Y., Harada, K.I., Sakai, I., Fujisawa, M. Int. J. Clin. Oncol. (2011)
- Metastatic collecting duct carcinoma of the kidney responded to sunitinib. Miyake, H., Haraguchi, T., Takenaka, A., Fujisawa, M. Int. J. Clin. Oncol. (2011)
- Orthotopic sigmoid neobladder after radical cystectomy: assessment of complications, functional outcomes and quality of life in 82 Japanese patients. Miyake, H., Furukawa, J., Muramaki, M., Takenaka, A., Fujisawa, M. BJU Int. (2010)
- Impact of body mass index on perioperative outcomes of laparoscopic radical nephrectomy in Japanese patients with clinically localized renal cell carcinoma. Miyake, H., Muramaki, M., Tanaka, K., Takenaka, A., Fujisawa, M. Int. J. Urol. (2010)
- Experience with various types of orthotopic neobladder in Japanese men: long-term follow-up. Miyake, H., Furukawa, J., Takenaka, A., Inoue, T.A., Yamanaka, N., Fujisawa, M. Urol. Int. (2010)
- Serum level of clusterin and its density in men with prostate cancer as novel biomarkers reflecting disease extension. Miyake, H., Muramaki, M., Furukawa, J., Kurahashi, T., Fujisawa, M. Urology (2010)
- Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: a prospective evaluation. Miyake, H., Kurahashi, T., Yamanaka, K., Kondo, Y., Muramaki, M., Takenaka, A., Inoue, T.A., Fujisawa, M. Urol. Oncol. (2010)
- Impact of sorafenib on health-related quality of life in Japanese patients with metastatic renal cell carcinoma: a prospective evaluation. Miyake, H., Kurahashi, T., Yamanaka, K., Kondo, Y., Takenaka, A., Inoue, T.A., Fujisawa, M. BJU Int. (2010)
- Expression of potential molecular markers in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. Miyake, H., Muramaki, M., Kurahashi, T., Takenaka, A., Fujisawa, M. Urol. Oncol. (2010)
- Development of "extended radical retropubic prostatectomy": a surgical technique for improving margin positive rates in prostate cancer. Miyake, H., Fujimoto, H., Komiyama, M., Fujisawa, M. Eur. J. Surg. Oncol (2010)
- Prediction of response to combined immunotherapy with interferon-alpha and low-dose interleukin-2 in metastatic renal cell carcinoma: expression patterns of potential molecular markers in radical nephrectomy specimens. Miyake, H., Sakai, I., Muramaki, M., Kurahashi, T., Takenaka, A., Fujisawa, M. Int. J. Urol. (2009)
- Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma. Miyake, H., Kurahashi, T., Takenaka, A., Inoue, T.A., Fujisawa, M. Urol. Oncol. (2009)
- Additional sampling of dorsal apex on systematic prostate biopsy: impact on early detection of prostate cancer. Miyake, H., Harada, K., Inoue, T.A., Takenaka, A., Hara, I., Fujisawa, M. Urology (2007)
- Significance of micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction in patients with clinically localized prostate cancer undergoing radical prostatectomy after neoadjuvant hormonal therapy. Miyake, H., Kurahashi, T., Hara, I., Takenaka, A., Fujisawa, M. BJU Int. (2007)
- Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores. Miyake, H., Kurahashi, T., Takenaka, A., Hara, I., Fujisawa, M. Urol. Int. (2007)
- Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR. Miyake, H., Hara, I., Kurahashi, T., Inoue, T.A., Eto, H., Fujisawa, M. Clin. Cancer Res. (2007)
- Limited significance of routine excretory urography in the follow-up of patients with superficial bladder cancer after transurethral resection. Miyake, H., Hara, I., Yamanaka, K., Inoue, T.A., Fujisawa, M. BJU Int. (2006)
- Enhanced expression of heat shock protein 27 following neoadjuvant hormonal therapy is associated with poor clinical outcome in patients undergoing radical prostatectomy for prostate cancer. Miyake, H., Muramaki, M., Kurahashi, T., Yamanaka, K., Hara, I., Fujisawa, M. Anticancer Res. (2006)
- The potential of clusterin inhibiting antisense oligodeoxynucleotide therapy for prostate cancer. Miyake, H., Hara, I., Fujisawa, M., Gleave, M.E. Expert. Opin. Investig. Drugs (2006)
- The limited significance of a longer duration of neoadjuvant hormonal therapy prior to radical prostatectomy for high-risk prostate cancer in Japanese men. Miyake, H., Sakai, I., Inoue, T.A., Hara, I., Fujisawa, M. Urol. Int. (2006)
- Expression of clusterin in prostate cancer correlates with Gleason score but not with prognosis in patients undergoing radical prostatectomy without neoadjuvant hormonal therapy. Miyake, H., Muramaki, M., Kurahashi, T., Yamanaka, K., Hara, I., Gleave, M., Fujisawa, M. Urology (2006)
- Clinicopathological features of patients with biochemical recurrence after radical prostatectomy without progressive rise in serum prostate-specific antigen. Miyake, H., Hara, I., Kurahashi, T., Muramaki, M., Yamanaka, K., Inoue, T.A., Fujisawa, M. Urol. Int. (2006)
- Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential. Miyake, H., Hara, I., Yamanaka, K., Muramaki, M., Gleave, M., Eto, H. Oncol. Rep. (2005)
- Prognostic significance of the tumor volume in radical prostatectomy specimens after neoadjuvant hormonal therapy. Miyake, H., Sakai, I., Harada, K., Takechi, Y., Hara, I., Eto, H. Urol. Int. (2005)
- Clinicopathological features of prostate cancer in Japanese men diagnosed on repeat transrectal ultrasound-guided biopsy. Miyake, H., Sakai, I., Harada, K., Hara, I., Eto, H. Int. J. Clin. Oncol. (2005)
- Preoperative prediction of final pathological features is not improved by the free-to-total prostate-specific antigen ratio in Japanese men with clinically localized prostate cancer. Miyake, H., Sakai, I., Harada, K., Hara, I., Eto, H. Int. J. Urol. (2005)
- Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Miyake, H., Yamanaka, K., Muramaki, M., Hara, I., Gleave, M.E. Neoplasia (2005)
- Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease. Miyake, H., Sakai, I., Harada, K., Hara, I., Eto, H. Int. J. Urol. (2005)
- Prognostic significance of insulin-like growth factor (IGF) binding protein-2 to IGF-binding protein-3 ratio in patients undergoing radical cystectomy for invasive transitional cell carcinoma of the bladder. Miyake, H., Hara, I., Yamanaka, K., Muramaki, M., Eto, H. BJU Int. (2005)
- Clinical outcome of oral uracil/tegafur (UFT) therapy for patients with hormone refractory prostate cancer. Miyake, H., Hara, I., Yamazaki, H., Eto, H. Oncol. Rep. (2005)
- Urinary levels of vascular endothelial growth factor in patients with prostate cancer as a predictor of disease progression. Miyake, H., Muramaki, M., Kurahashi, T., Yamanaka, K., Hara, I. Anticancer Res. (2005)
- Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer. Miyake, H., Hara, I., Eto, H. BJU Int. (2005)
- Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy?. Miyake, H., Sakai, I., Harada, K., Hara, I., Eto, H. Int. J. Urol. (2005)
- Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic. Miyake, H., Hara, I., Gleave, M.E. Int. J. Urol. (2005)
- Enhanced expression of the secreted form of clusterin following neoadjuvant hormonal therapy as a prognostic predictor in patients undergoing radical prostatectomy for prostate cancer. Miyake, H., Yamanaka, K., Muramaki, M., Kurahashi, T., Gleave, M., Hara, I. Oncol. Rep. (2005)
- Clinical outcome of combined immunotherapy with low-dose interleukin-2 and interferon-alpha for Japanese patients with metastatic renal cell carcinoma who had undergone radical nephrectomy: a preliminary report. Miyake, H., Hara, I., Sakai, I., Harada, K., Inoue, T.A., Eto, H., Takechi, Y., Fujisawa, M. Int. J. Clin. Oncol. (2005)
- Antisense oligodeoxynucleotide therapy for bladder cancer: recent advances and future prospects. Miyake, H., Hara, I., Fujisaw, M., Gleave, M.E. Expert. Rev. Anticancer. Ther (2005)
- Significance of routine transition zone biopsies in Japanese men undergoing transrectal ultrasound-guided prostate biopsies. Miyake, H., Kurahashi, T., Muramaki, M., Yamanak, K., Hara, I. Int. J. Urol. (2005)
- Significance of cancer detection in the anterior lateral horn on systematic prostate biopsy: the effect on pathological findings of radical prostatectomy specimens. Miyake, H., Sakai, I., Ishimura, T., Hara, I., Eto, H. BJU Int. (2004)
- Significance of renal function in changes in acid-base metabolism after orthotopic bladder replacement: colon neobladder compared with ileal neobladder. Miyake, H., Hara, S., Eto, H., Arakawa, S., Kamidono, S., Hara, I. Int. J. Urol. (2004)
- Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer. Miyake, H., Sakai, I., Harada, K., Hara, I., Eto, H. Int. J. Urol. (2004)
- Increased detection of clinically significant prostate cancer by additional sampling from the anterior lateral horns of the peripheral zone in combination with the standard sextant biopsy. Miyake, H., Sakai, I., Harada, K., Hara, I., Eto, H. Int. J. Urol. (2004)
- Health-related quality of life after chemotherapy for advanced germ cell tumors: a comparison of standard-dose and high-dose chemotherapy. Miyake, H., Muramaki, M., Eto, H., Kamidono, S., Hara, I. Int. J. Urol. (2004)
- Health-related quality of life in patients with testicular cancer: a comparative analysis according to therapeutic modalities. Miyake, H., Muramaki, M., Eto, H., Kamidono, S., Hara, I. Oncol. Rep. (2004)
- Global analysis of gene expression profiles in ileum in a rat bladder augmentation model using cDNA microarrays. Miyake, H., Hara, S., Eto, H., Kamidono, S., Hara, I. Int. J. Urol. (2004)
- Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression. Miyake, H., Hara, I., Kamidono, S., Gleave, M.E., Eto, H. Oncol. Rep. (2003)
- Prediction of the extent of prostate cancer by the combined use of systematic biopsy and serum level of cathepsin D. Miyake, H., Hara, I., Eto, H. Int. J. Urol. (2003)
- Increased urinary 8-hydroxy-2'-deoxyguanosine excretion after ileal neobladder replacement. Miyake, H., Eto, H., Takechi, Y., Kamidono, S., Hara, I. BJU Int. (2003)
- Pathological findings of radical prostatectomy specimens in Japanese men diagnosed on single core positive prostate biopsy in eight with a Gleason score less than 4. Miyake, H., Ono, Y., Park, S.J., Hara, I., Eto, H. Int. J. Urol. (2003)
- Clinical outcome of bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract. Miyake, H., Eto, H., Hara, S., Okada, H., Kamidono, S., Hara, I. Int. J. Urol. (2002)
- Novel therapeutic strategy for advanced prostate cancer using antisense oligodeoxynucleotides targeting anti-apoptotic genes upregulated after androgen withdrawal to delay androgen-independent progression and enhance chemosensitivity. Miyake, H., Hara, I., Kamidono, S., Gleave, M.E. Int. J. Urol. (2001)
